Fresenius SE

Fresenius improves credit facility terms
Fresenius considerably improved the terms of its 2008 syndicated credit agreement through an amendment supported by a vast majority of its lenders. >>>

Fresenius Medical Care Reports Excellent 4th-Quarter and Full-Year 2009 Results; Provides strong outlook for 2010 (for additional tables see PDF-file)
The company reached its financial targets for 2009, set new records and proposes its 13th consecutive annual dividend increase. >>>

Fresenius SE: Record financial results in 2009 − All financial targets met or exceeded − Positive outlook for 2010 (for additional tables see PDF-file)
Ulf Mark Schneider, CEO of Fresenius SE: “Fresenius took full advantage of its business opportunities in the past year. Despite a challenging macroeconomic environment, we have met or even exceeded our earnings guidance for 2009. Our comprehensive and well-diversified portfolio of products and services as well as our global presence proved to be valuable assets..." >>>

Fresenius Group’s initial relief assists over 185,000 Haiti earthquake victims
Fresenius is coordinating efforts throughout its global corporate organization in response to the Haitian earthquake tragedy. >>>

Fresenius Medical Care Successfully Places Senior Notes in the Amount of €250 million
Fresenius Medical Care AG & Co. KGaA (the “Company” or “Fresenius Medical Care”), the world’s largest provider of dialysis products and services, today announced the pricing of Senior Notes due 2016 in the principal amount of €250 million issued by FMC Finance VI S.A., a wholly owned subsidiary of the Company (the “Senior Notes”). >>>